Ourpharma recalls
Ourpharma appears in 4 official U.S. recall notices indexed by RecallRadar, most recently on 2026-09-16.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 4 |
|---|---|
| Published | 2022-12-21 to 2026-09-16 |
| By agency | FDA Drug (4) |
| By classification | Class II (2), Class III (2) |
| By status | terminated (3), ongoing (1) |
| Distribution named in notices | IL, MO, US |
Recalls
- fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City Lake, Fayetteville,…
FDA Drug · Class II · 2026-09-16 · Ourpharma
Reason: Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026). - HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville,…
FDA Drug · Class III · 2025-04-30 · Ourpharma
Reason: Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification.. - FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. C…
FDA Drug · Class III · 2023-02-01 · Ourpharma
Reason: Short Fill: Underfilled units. - FentaNYL Citrate 2.5 mg/50 mL (50mcg/ml) Injection Solution, Preservative Free, Single Use 50 ml Cassette, Rx Only, Repackaged by OurPharma…
FDA Drug · Class II · 2022-12-21 · Ourpharma
Reason: Underfilled units.